🏛️ Verified NIH Record • Updated 2026-07-29
Study of BHV-1300 in Graves' Disease (NCT06980649)
An Open-Label Biomarker Study of BHV-1300 in Graves' Disease
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Biohaven Therapeutics Ltd.
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves' Disease and to explore its effect on disease-specific biomarkers.
Who can join: Review the eligibility criteria below.
Location: Site-103 — South Gate, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Site-103 — South Gate, California
- Site-100 — Miami, Florida
- Site-104 — Columbus, Georgia
- Site-108 — Greenville, North Carolina
- Site-110 — Canton, Ohio
- Site-107 — Memphis, Tennessee
- Site-109 — Dallas, Texas
- Site-106 — Houston, Texas
- Site-101 — Houston, Texas
- Site-105 — Shavano Park, Texas
- Site-004 — Fitzroy,
- Site-011 — Herston,
- Site-001 — Kotara,
- Site-003 — Melbourne,
- Site-010 — Oaklands Park,
- Site-008 — Parkville,
- Site-006 — St Leonards,
- Site-002 — Torquay,
📞 Contact the Study Coordinator
Phone: (203) 404-0410
Email: clinicaltrials@biohavenpharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Graves Disease
- Evaluating an AI Tool for Detecting Thyrotoxic States — San Francisco, California
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease — New Hyde Park, New York
- Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease — Burbank, California
- Preoperative Corticosteroids in Autoimmune Thyroid Disease — Indianapolis, Indiana
- NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease — Torrance, California
Explore by condition: All Graves Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.